Home

NLS Pharmaceutics Ltd. - Warrant (NLSPW)

0.0202
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 11th, 5:20 AM EDT
QuoteNewsPress ReleasesChartHistorical
NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letterbenzinga.com
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) recently released a comprehensive shareholder letter by its CEO, Alex Zwyer, detailing recent achievements and ongoing endeavors.
Via Benzinga · August 28, 2023